Medication
Gonadotrophins (injectable fertility hormones)
Gonadotrophins are injectable hormone medicines used in fertility treatment to stimulate the ovaries to develop several eggs. They are used under close monitoring as part of treatments such as IVF and egg freezing, and sometimes to induce ovulation.
What gonadotrophins do
Gonadotrophins are injectable hormones based on follicle-stimulating hormone (FSH) activity, sometimes with luteinising hormone (LH) activity. They stimulate the ovaries to develop several eggs during treatments such as IVF and egg freezing, and are sometimes used to induce ovulation. They are always used with monitoring so your clinic can adjust care to your response.
Safety and monitoring
Because these medicines increase ovarian activity, clinics monitor with ultrasound scans — often alongside blood estradiol tests — and watch for ovarian hyperstimulation syndrome (OHSS). The HFEA notes that about a third of people get mild OHSS, which is usually managed at home, while severe OHSS is uncommon but occasionally serious. Warning signs to report include severe abdominal pain and swelling, nausea or vomiting, breathlessness, faintness, and reduced urine output, typically in the week after egg collection.
This page does not provide dosing. Follow the exact instructions from your own clinic and the current product information (SmPC) for your specific medicine. Never adjust doses, timing, or stopping without your clinic’s guidance.
Common uses in fertility care
- Ovarian stimulation during IVF
- Stimulating egg development for egg freezing
- Inducing ovulation in some people who do not ovulate, including some with PCOS
How it is usually given
- Given by injection, usually under the skin
Common effects
- Injection-site reactions such as pain, redness, or bruising
- Headache
- Bloating or abdominal discomfort, and ovarian cysts
- Mild ovarian hyperstimulation syndrome (OHSS)
Serious warnings
- Ovarian hyperstimulation syndrome (OHSS): the HFEA notes about a third of people get mild OHSS, while severe OHSS is uncommon but can occasionally be serious
- Increased chance of multiple pregnancy in some treatments
- Very rarely, blood clots (thromboembolism)
Monitoring
- Ultrasound scans, often with blood estradiol tests, during stimulation
- Watching for symptoms of OHSS
- Written by
- Sam Rivera · Health writer
- Medically reviewed by
- Dr Lena Park · Reproductive endocrinologist (medical reviewer)
- Last reviewed
- Next review due
Sources
- Summaries of Product Characteristics for gonadotrophin medicineselectronic medicines compendium (emc) / MHRA-approved labelling · Published 1 February 2025 · Accessed 2 July 2026
- Risks of fertility treatmentHuman Fertilisation and Embryology Authority (HFEA) · Published 7 April 2016 · Accessed 19 July 2026
- IVFNHS · Published 15 April 2025 · Accessed 19 July 2026
- ESHRE guidelines on assisted reproductive technology and ovarian stimulationEuropean Society of Human Reproduction and Embryology (ESHRE) · Published 1 May 2019 · Accessed 30 June 2026
See something wrong or out of date? Report an issue or correction.